Please login to the form below

Not currently logged in
Email:
Password:

ISPE looks to Boehringer for new VP of Europe

Thomas Zimmer was senior VP at German pharma company
ispe thomas zimmer

Thomas Zimmer has left his senior VP role at Boehringer Ingelheim to join the International Society for Pharmaceutical Engineering (ISPE) as VP of European operations.

In his new role, Zimmer will be responsible for leading ISPE's business development and advancing strategic relationships in Europe.

He spent 32 years at German pharma company Boehringer, serving in senior roles across development, production, quality and supply chain management

In addition, Zimmer has experience at the European Federations of Pharmaceutical Industry Associations (EFPIA) and as a member of the World Health Organization's (WHO) IMPACT taskforce.

"Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large," said ISPE President and CEO Nancy Berg.

"Thomas's first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world."

14th November 2013

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....